openPR Logo
Press release

Genomics Market Expected To Be Worth US$ 49,996.15 million by 2027 with Business Market Insights: Eurofins Scientific, QIAGEN, BGI, Illumina, Inc., Danaher

07-28-2021 10:49 AM CET | Health & Medicine

Press release from: The Insight Partners

Genomics Market

Genomics Market

The Genomics Market was valued at US$ 19,084.74 million in 2019 and is projected to reach US$ 49,996.15 million by 2027; it is expected to grow at a CAGR of 13.1% from 2020 to 2027.

Genomic sequencing is rapidly transitioning into clinical practice. Also, substantial government investments, totaling over US$ 4 billion in at least 14 countries, are supporting its implementation into healthcare systems. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to the implementation and gathering evidence for broader adoption, which is bolstering the market growth.

Scientists are collaborating to generate and share genomic sequence data information and apply it to disease diagnosis and control efforts. The US is increasing its ability to track the mutations of novel coronavirus with genomic sequencing as experts warned that new variants drive up a number of cases and hospitalizations. For instance, the US ranked 43rd in genome sequencing projects by sequencing 3% of the sample, according to the GISAID Initiative, a global genome sequencing database project. The sequencing of the genome can aid in the fight against the COVID-19 outbreak and the newly emerging variants.

(**Note: The sample of this report is updated with COVID-19 impact analysis**)

To Know How COVID-19 Pandemic Will Impact Global Genomics Market | Get a Sample Copy of Report, Click Here:
https://www.theinsightpartners.com/sample/TIPTE100000730/?source=openpr-10411

Genomics Market Top Leading Vendors :-
• Illumina, Inc.
• Danaher
• F. HOFFMANN-LA ROCHE LTD.
• BIO-RAD LABORATORIES INC.
• General Electric Company
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Eurofins Scientific
• QIAGEN
• BGI

Genomics Market – by Technology
• Sequencing
• Microarray
• Polymerase Chain Reaction
• Nucleic Acid Extraction and Purification
• Others

Genomics Market – by Product & Services
• Instruments/Systems
• Consumables
• Services

Genomics Market – by Application
• Diagnostics
• Drug Discovery and Development
• Precision/Personalized Medicine
• Agriculture & Animal Research
• Others

Genomics Market – by End User
• Research Centers
• Hospitals & Clinics
• Biotechnology & Pharmaceutical Companies
• Others

In this extensive study, the Global Genomics Market has been analyzed on the basis its product and application. Geographically, North America, Asia Pacific, Europe, Latin America and Middle East & Africa have been identifies as the key regions among the others. This Market region has been identified to acquire the highest share position in this market and is expected to remain the same for the next few years.

The competitive landscape of the Genomics Market has been examined on the basis of market share analysis of key players. Complete market data about the factors is assessed to help vendors take strategic decisions that can strengthen their positions in the market and lead to more effective and larger stake in the global market. Pricing and cost teardown analysis for service offerings of key players has also been undertaken for the study.

Interested in Purchasing this Report? Click here @
https://www.theinsightpartners.com/buy/TIPTE100000730/?source=openpr-10411

The study objectives of this report are:
• To analyze global Genomics Market status, future forecast, growth opportunity, key market and key players.
• To present the Genomics development in United States, Europe and China.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by product type, market and key regions.

It provides in-depth predictions of revenue of the market as a whole as well as each and every application section. The competitive landscape is plotted, reliant on the product and technology.

This study also offers a summary of pricing trends and subsidiary factors that will be manipulating the pricing in the Global Genomics Market. The market study, assessment, and market sizing have been done applying a combination of both, top-down and bottom-up methods.

Table of Content:-
Chapter 1 Genomics Market Overview
Chapter 2 Market Data Analysis
Chapter 3 Market Technical Data Analysis
Chapter 4 Market Government Policy and News
Chapter 5 Market Productions Supply Sales Demand Market Status and Forecast
Chapter 6 Global Market Manufacturing Process and Cost Structure
Chapter 7 Genomics Market Key Manufacturers
Chapter 8 Up and Down Stream Industry Analysis
Chapter 9 Marketing Strategy - Market y Analysis
Chapter 10 Market Development Trend Analysis
Chapter 11 Global Genomics Market New Project Investment Feasibility Analysis

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genomics Market Expected To Be Worth US$ 49,996.15 million by 2027 with Business Market Insights: Eurofins Scientific, QIAGEN, BGI, Illumina, Inc., Danaher here

News-ID: 2339390 • Views:

More Releases from The Insight Partners

Green Building Materials Market Forecast 2031: Valued at US$ 791.93 Billion, Growing at 10.4% CAGR
Green Building Materials Market Forecast 2031: Valued at US$ 791.93 Billion, Gro …
The Green Building Materials Market size is expected to reach US$ 791.93 billion by 2031. The market is anticipated to register a CAGR of 10.4% during 2025-2031. Global Green Building Materials Market 2031 Report give our customers an exhaustive and top to bottom examination of Green Building Materials Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division,
Text Analytics Market Growth Forecast: Valued at US$ 29.53 Billion by 2031
Text Analytics Market Growth Forecast: Valued at US$ 29.53 Billion by 2031
The Text Analytics Market is evolving rapidly, fueled by breakthroughs in artificial intelligence, natural language processing, and the exploding volume of unstructured data from social media, customer feedback, and enterprise communications. Businesses worldwide are turning to text analytics solutions to unlock hidden insights, enhance customer experiences, and drive data-informed strategies. As organizations navigate complex data landscapes, text analytics stands out as a critical tool for competitive advantage. Download PDF: -https://www.theinsightpartners.com/sample/TIPTE100000198?utm_source=Openpr&utm_medium=10413 In today's
Genome Editing Market: Trends, Opportunities, and Future Outlook
Genome Editing Market: Trends, Opportunities, and Future Outlook
The genome editing market has emerged as one of the most dynamic and transformative sectors in biotechnology, driven by advancements in genetic engineering technologies and increasing applications across various fields. As of 2024, the market is witnessing significant growth, fueled by the rising demand for personalized medicine, agricultural innovations, and therapeutic solutions. This article explores the current trends, opportunities, and future outlook of the genome editing market. Get the sample request
Transdermal Drug Delivery System Market to Reach US$ 51,949.74 Million by 2030
Transdermal Drug Delivery System Market to Reach US$ 51,949.74 Million by 2030
The Transdermal Drug Delivery System Market is entering a new era of growth, driven by rising demand for non-invasive drug administration, patient-friendly therapies, and technological innovation. According to industry analysis, the market size is expected to grow from US$ 37,230.28 million in 2022 to US$ 51,949.74 million by 2030, recording a CAGR of 4.3% during 2022-2030. This trajectory highlights the increasing adoption of transdermal patches, gels, sprays, and other advanced

All 5 Releases


More Releases for Genomic

Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025 As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad Japan: Recent Industry Developments ✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034" Genomic & Epigenomic Profiling Market Size is
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Genomic Biomarker Market Size Expected to Be by 2034? The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the